A CRISPR/Cas9-Engineered <i>ARID1A</i> -Deficient Human Gastric Cancer Organoid Model Reveals Essential and Nonessential Modes of Oncogenic TransformationYuan‐Hung Lo, Calvin J. Kuo, Walter D. Sobba et al.|Cancer Discovery|2021Cited by 166
Mutation Patterns Predict Drug Sensitivity in Acute Myeloid LeukemiaGuangrong Qin, Pamela S. Becker, Jin Dai et al.|Clinical Cancer Research|2024Cited by 18
Integrated proteogenomic and metabolomic profiling of acute myeloid leukemias to identify molecular subtypes and associated therapy targetsShih-Chun A. Chu, Paul Piehowski, Yi Hsiao et al.|Nature Cancer|2026Cited by 1